Turkish study aims to define normal muscle mass for better sarcopenia diagnosis
NCT ID NCT07510009
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study measured muscle mass, grip strength, and walking speed in 145 healthy Turkish adults aged 18-39 and 65-99. The goal was to create reference values specific to the Turkish population, so doctors can better diagnose sarcopenia—a condition where people lose muscle mass and strength as they age. No treatment was tested; this was an observational study to improve diagnostic accuracy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
145 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
city hospital
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Having mental and physical capacity * Being between 18-39 and 65-99 years of age * Being able to ambulate independently or with support Exclusion Criteria: * Pregnancy * Infection * Pacemaker or metallic implant * Peripheral circulatory disorder * Known concomitant malignancy, end-stage organ failure * Known concomitant central nervous system and/or peripheral nervous system disease * History of genetic disease * Coagulopathy * Amputation * Patients with a history of genetic disease * Patients weighing \>120 kg
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sarcopenia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, 06800, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a robotic exoskeleton rebuild aging legs?
- Can tai chi lift mood and quality of life in older adults losing muscle?
- Can a bone drug also build muscle? trial tests denosumab for sarcopenia
- Can tai chi rebuild strength and balance in aging muscles?
- Can a bone drug rebuild muscle? trial tests denosumab for sarcopenia
- Muscle loss may predict who struggles after cancer surgery